Free Trial

Adit EdTech Acquisition (ADEX) Competitors

Adit EdTech Acquisition logo
$5.38 0.00 (0.00%)
As of 09/12/2025

ADEX vs. LIFW, WEJOF, QXO, YY, SXTC, ENTA, EPRX, TLSA, KRMD, and IPHA

Should you be buying Adit EdTech Acquisition stock or one of its competitors? The main competitors of Adit EdTech Acquisition include MSP Recovery (LIFW), Wejo Group (WEJOF), QXO (QXO), JOYY (YY), China SXT Pharmaceuticals (SXTC), Enanta Pharmaceuticals (ENTA), Eupraxia Pharmaceuticals (EPRX), Tiziana Life Sciences (TLSA), KORU Medical Systems (KRMD), and Innate Pharma (IPHA).

Adit EdTech Acquisition vs. Its Competitors

Adit EdTech Acquisition (NYSE:ADEX) and MSP Recovery (NASDAQ:LIFW) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, earnings, valuation, institutional ownership, analyst recommendations, dividends and risk.

0.8% of Adit EdTech Acquisition shares are held by institutional investors. Comparatively, 3.8% of MSP Recovery shares are held by institutional investors. 0.3% of Adit EdTech Acquisition shares are held by company insiders. Comparatively, 86.5% of MSP Recovery shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Adit EdTech Acquisition has a net margin of 0.00% compared to MSP Recovery's net margin of -906.67%. Adit EdTech Acquisition's return on equity of 0.00% beat MSP Recovery's return on equity.

Company Net Margins Return on Equity Return on Assets
Adit EdTech AcquisitionN/A N/A -41.90%
MSP Recovery -906.67%-6.25%-2.39%

In the previous week, MSP Recovery had 2 more articles in the media than Adit EdTech Acquisition. MarketBeat recorded 2 mentions for MSP Recovery and 0 mentions for Adit EdTech Acquisition. Adit EdTech Acquisition's average media sentiment score of 0.00 beat MSP Recovery's score of -0.15 indicating that Adit EdTech Acquisition is being referred to more favorably in the media.

Company Overall Sentiment
Adit EdTech Acquisition Neutral
MSP Recovery Neutral

Adit EdTech Acquisition has higher earnings, but lower revenue than MSP Recovery.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adit EdTech AcquisitionN/AN/A-$18.66MN/AN/A
MSP Recovery$10.73M1.08-$56.35M-$142.50-0.01

Adit EdTech Acquisition has a beta of -0.23, indicating that its share price is 123% less volatile than the S&P 500. Comparatively, MSP Recovery has a beta of -2.38, indicating that its share price is 338% less volatile than the S&P 500.

Summary

Adit EdTech Acquisition and MSP Recovery tied by winning 5 of the 10 factors compared between the two stocks.

Get Adit EdTech Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADEX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ADEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADEX vs. The Competition

MetricAdit EdTech AcquisitionData processing & preparation IndustryMedical SectorNYSE Exchange
Market Cap$47.88M$1.96B$5.70B$21.42B
Dividend YieldN/A3.15%5.72%3.49%
P/E RatioN/A6.6675.8829.84
Price / SalesN/A1.58492.6769.96
Price / CashN/A41.5125.8118.13
Price / Book-0.801.2012.834.61
Net Income-$18.66M-$4.91M$3.28B$998.80M
7 Day PerformanceN/A-1.49%0.17%1.09%
1 Month PerformanceN/A-5.24%4.54%4.46%
1 Year PerformanceN/A7.79%68.32%14.45%

Adit EdTech Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADEX
Adit EdTech Acquisition
N/A$5.38
flat
N/AN/A$47.88MN/A0.007
LIFW
MSP Recovery
N/A$1.86
-27.1%
N/A-93.5%$12.21M$10.73M-0.013
WEJOF
Wejo Group
N/A$0.00
flat
N/AN/A$11K$8.40M0.00300
QXO
QXO
3.3532 of 5 stars
$21.47
-2.2%
$33.73
+57.1%
+44.1%$14.46B$1.95B-2.35195Positive News
YY
JOYY
N/A$63.68
+1.8%
N/A+72.8%$3.43B$2.24B19.247,450Positive News
SXTC
China SXT Pharmaceuticals
1.3112 of 5 stars
$1.48
-10.6%
N/A-65.1%$191.45M$1.74M0.0090News Coverage
Positive News
Short Interest ↓
Gap Down
ENTA
Enanta Pharmaceuticals
4.1639 of 5 stars
$9.04
+1.5%
$22.25
+146.1%
-40.0%$190.48M$67.64M-2.09160News Coverage
Analyst Forecast
EPRX
Eupraxia Pharmaceuticals
2.4986 of 5 stars
$5.27
0.0%
$11.00
+108.8%
+105.4%$189.51MN/A-6.2029
TLSA
Tiziana Life Sciences
0.5716 of 5 stars
$1.85
+14.2%
N/A+83.8%$189.29MN/A0.008News Coverage
Short Interest ↑
KRMD
KORU Medical Systems
2.5628 of 5 stars
$4.01
-1.7%
$4.63
+15.3%
+57.6%$188.64M$36.85M-44.5680Positive News
IPHA
Innate Pharma
2.6705 of 5 stars
$2.04
flat
$11.00
+439.2%
-8.6%$188.06M$12.62M0.00220News Coverage
Positive News
Upcoming Earnings

Related Companies and Tools


This page (NYSE:ADEX) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners